Article Information
History
- June 8, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Russell M. Petrak, M.D.1,*,
- Nathan C. Skorodin, Pharm.D.1,**,
- Nicholas W. Van Hise, Pharm.D., BCPS1,
- Robert M. Fliegelman, D.O.1,
- Jonathan Pinsky, M.D.2,
- Vishal Didwania, M.D.3,
- Michael Anderson, M.D.4,
- Melina Diaz, M. D.5,
- Kairav Shah, M.D.5,
- Vishnu V. Chundi, M.D.6,
- David W. Hines, M.D.6,
- Brian P. Harting, M.D.7,
- Kamo Sidwha, M.D.6,
- Brian Yu, M.D.6,
- Paul Brune, M.D.8,
- Anjum Owaisi, M.D.9,
- David Beezhold, D.O.3,
- Joseph Kent, M.D.10,
- Dana Vais, M.D.6,
- Alice Han, M.D.6,
- Neethi Gowda, M.D.11,
- Nishi Sahgal, M.D.12,
- Jan Silverman, D.O.13,
- Jonathan Stake, M.D.14,
- Jenie Nepomuceno, M.D.15 and
- Renuka Heddurshetti, M.D.16
- 1Metro Infectious Disease Consultants, Burr Ridge, Illinois
- 2Metro Infectious Disease Consultants, Naperville, Illinois
- 3Metro Infectious Disease Consultants, Elmhurst, Illinois
- 4Metro Infectious Disease Consultants, Kankakee, Illinois
- 5Metro Infectious Disease Consultants, Atlanta, Georgia
- 6Metro Infectious Disease Consultants, Chicago, Illinois
- 7Metro Infectious Disease Consultants, Downers Grove, Illinois
- 8Metro Infectious Disease Consultants, Kansas City, Missouri
- 9Metro Infectious Disease Consultants, Bolingbrook, Illinois
- 10Metro Infectious Disease Consultants, Oak Lawn, Illinois
- 11Metro Infectious Disease Consultants, Troy, Michigan
- 12Metro Infectious Disease Consultants, Hinsdale, Illinois
- 13Metro Infectious Disease Consultants, Royal Oak, Michigan
- 14Metro Infectious Disease Consultants, Waukegan, Illinois
- 15Metro Infectious Disease Consultants, McHenry, Illinois
- 16Metro Infectious Disease Consultants, Detroit, Michigan
Posted June 08, 2020.
Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS-CoV-2
